Comparison of PARPis with Angiogenesis Inhibitors and Chemotherapy for Maintenance in Ovarian Cancer: A Network Meta-Analysis.

Yanling FengHe HuangTing WanChuyao ZhangChongjie TongJi Hong Liu

Published in: Advances in therapy (2019)

PARPi as maintenance treatment improved PFS in ovarian cancer and was relatively safer in terms of implications caused by AEs when compared to AIs. This network meta-analysis provides valuable evidence and significant insights into treatment of ovarian cancer.

Keyphrases

systematic review
squamous cell carcinoma
randomized controlled trial
radiation therapy
vascular endothelial growth factor
replacement therapy